Post-approval studies (Phase 4)WithdrawnNCT01631513
What this trial is testing
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
Who this might be right for
PainChronic Back PainChronic Low Back Pain+1 more
Janssen Scientific Affairs, LLC